Literature DB >> 20832999

The potential use of protein kinase D inhibitors for prevention/treatment of epidermal tumors.

Senthil Nathan Arun1, Ding Xie, M Ernest Dodd, Xiaofeng Zhong, Wendy B Bollag.   

Abstract

BACKGROUND: The serine/threonine kinase protein kinase D (PKD) has been proposed to be a pro-proliferative, anti-differentiative signal in epidermal keratinocytes. Indeed, the phorbol ester tumor promoter, 12-O-tetradecanoylphorbol 13-acetate (TPA) induces biphasic PKD activation, which mirrors the biphasic response of initial differentiation followed by proliferation and tumor promotion seen in TPA-treated keratinocytes in vitro and epidermis in vivo.
OBJECTIVE: Our objective was to test the idea that PKD's pro-proliferative and/or anti-differentiative effects in keratinocytes contribute to TPA-induced tumorigenesis.
METHODS: Using western analysis and assays of keratinocyte proliferation and differentiation, we investigated the effect of inhibitors of PKD on keratinocyte function.
RESULTS: We found that overexpression of a constitutively active PKD mutant increased, and of a dominant-negative PKD mutant decreased, keratinocyte proliferation. A recently described selective PKD inhibitor showed low potency to inhibit keratinocyte proliferation or PKD activation. Therefore, we tested the ability of known only relatively selective PKD inhibitors on keratinocyte function and protein kinase activation. H89 {N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinoline-sulfonamide}, a reported inhibitor of PKD and cAMP-dependent protein kinase, enhanced the effect of a differentiating agent on a marker of keratinocyte differentiation. Another reported non-selective PKD inhibitor, resveratrol stimulated differentiation and inhibited proliferation. The protein kinase C/PKD inhibitor Gö6976 blocked the increase in proliferation (as measured by DNA specific activity) induced by chronic TPA without affecting the initial TPA-elicited differentiation.
CONCLUSION: Our results support the idea that relatively selective PKD inhibitors, such as Gö6976, H89 and resveratrol, might be useful for preventing/treating epidermal tumorigenesis without affecting keratinocyte differentiation.
Copyright © 2010 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20832999      PMCID: PMC2965187          DOI: 10.1016/j.jdermsci.2010.07.015

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  40 in total

Review 1.  Selective clonal expansion and microenvironmental permissiveness in tobacco carcinogenesis.

Authors:  Harry Rubin
Journal:  Oncogene       Date:  2002-10-21       Impact factor: 9.867

2.  Systemic two-stage carcinogenesis in the epithelium of the forestomach of mice using 7,12-dimethylbenz(a)anthracene as initiator and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate as promoter.

Authors:  K Goerttler; H Loehrke; J Schweizer; B Hesse
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

3.  Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases: inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation.

Authors:  J R Stewart; K L Christman; C A O'Brian
Journal:  Biochem Pharmacol       Date:  2000-11-01       Impact factor: 5.858

4.  Basic calcium phosphate crystals activate p44/42 MAPK signal transduction pathway via protein kinase Cmicro in human fibroblasts.

Authors:  Paul M Reuben; Yubo Sun; Herman S Cheung
Journal:  J Biol Chem       Date:  2004-06-09       Impact factor: 5.157

Review 5.  Protein kinase D and keratinocyte proliferation.

Authors:  Wendy B Bollag; M Ernest Dodd; Brian A Shapiro
Journal:  Drug News Perspect       Date:  2004-03

6.  Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5.

Authors:  Rick B Vega; Brooke C Harrison; Eric Meadows; Charles R Roberts; Philip J Papst; Eric N Olson; Timothy A McKinsey
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

7.  Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling.

Authors:  Peter Storz; Heike Döppler; Alex Toker
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

8.  Inhibition of protein kinase C by resveratrol.

Authors:  Simon J Slater; Jodie L Seiz; Anthony C Cook; Brigid A Stagliano; Christopher J Buzas
Journal:  Biochim Biophys Acta       Date:  2003-01-20

9.  Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway.

Authors:  Peter Storz; Alex Toker
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

10.  Putative conventional protein kinase C inhibitor Gödecke 6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] stimulates transglutaminase activity in primary mouse epidermal keratinocytes.

Authors:  Brian A Shapiro; Sagarika Ray; EunMi Jung; William T Allred; Wendy B Bollag
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030

View more
  5 in total

1.  Protein kinase D1 deficiency promotes differentiation in epidermal keratinocytes.

Authors:  Vivek Choudhary; Lawrence O Olala; Ismail Kaddour-Djebbar; Inas Helwa; Wendy B Bollag
Journal:  J Dermatol Sci       Date:  2014-10-02       Impact factor: 4.563

2.  Ultraviolet activation of PKD: implications for skin cancer.

Authors:  Wendy B Bollag; Roni J Bollag
Journal:  Future Oncol       Date:  2011-04       Impact factor: 3.404

3.  Preventative effects of antioxidants on changes in sebocytes, outer root sheath cells, and Cutibacterium acnes-pretreated mice by particulate matter: No significant difference among antioxidants.

Authors:  Mi Hee Kwack; Dae-Lyong Ha; Weon Ju Lee
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

4.  PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer.

Authors:  Caroline Spasojevic; Elisabetta Marangoni; Sophie Vacher; Franck Assayag; Didier Meseure; Sophie Château-Joubert; Martine Humbert; Manale Karam; Jean Marc Ricort; Christian Auclair; Marie Regairaz; Ivan Bièche
Journal:  Oncotarget       Date:  2018-05-01

Review 5.  Role of Resveratrol in Regulating Cutaneous Functions.

Authors:  Si Wen; Jiechen Zhang; Bin Yang; Peter M Elias; Mao-Qiang Man
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-14       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.